Group 1 - Haixi New Drug (02637) rose nearly 5%, being a commercial-stage pharmaceutical company with integrated R&D, production, and sales capabilities, and a pipeline of innovative drugs under development [1] - Paige Biopharma-B (02565) increased over 4.1%, with cornerstone investors holding a total of 9.5845 million H shares, accounting for approximately 3.43% of the company's total issued H shares [1] - Naxin Micro (02676) surged over 5% to reach a new high of 118.4 HKD, operating under a fabless model focused on chip R&D and design, outsourcing wafer manufacturing and most packaging testing [1] - Huaxin Building Materials (06655) rose 1.46%, with a major shareholder planning to increase its A-share holdings by no less than 200 million RMB and no more than 400 million RMB within six months [1] Group 2 - Dairy stocks saw an uptick, with Modern Farming (01117) rising 6.21% and Youran Dairy (09858) increasing 6.29%, following the Ministry of Commerce's announcement of temporary countervailing measures against EU dairy imports [2] - Gakos-B (01167) rose over 2.7% after announcing a collaboration with AstraZeneca on its self-developed Pan-KRAS inhibitor JAB-23E73 [2] - Junda Co. (02865) increased over 4.1% after announcing a strategic investment in Shangyi Optoelectronics, focusing on perovskite battery technology applications in space energy [2] - Qiming Medical-B (02500) rose nearly 6% after submitting all application materials for CE MDR certification of its Cardiovalve system in Europe [2] Group 3 - Brain Dynamics-B (06681) saw a slight increase of 0.32%, participating in a national major science and technology project focused on the prevention and treatment of cancer and cardiovascular diseases [3] - Hesai Technology (02525) rose over 3.3% after announcing a strategic partnership with Meituan drones for mass production of its second-generation solid-state lidar [4] Group 4 - Hut8 (HUT.US) continued to rise by 4.13%, with a total increase of 37% over three trading days, following an upgrade of its target price to 85 USD by StoneX [5] - Unusual Machines (UMAC.US) surged 9.24%, with a total increase of 45% over three trading days, after receiving a 3.75 million USD order from Performance Drone Works [5] - Hycroft Mining (HYMC.US) opened with a 10.69% increase, having risen 460% since September, due to successful exploration drilling confirming high-grade silver continuity [6] - Sony (SONY.US) rose 2.1% after acquiring a 41% stake in Peanuts Holdings for 630 million CAD, which holds the rights to the Peanuts comic [7] - Novo Nordisk (NVO.US) increased by 7.3% after the FDA approved its first oral GLP-1 weight loss drug, Wegovy, set to launch in January at a starting price of 149 USD per month [7] - ZIM Integrated Shipping Services (ZIM.US) rose 5.78% as the board evaluates multiple acquisition proposals from strategic investors [7]

Group 1 - The core team led by Dr. Lan Guocheng from the University of Hong Kong recognizes the industrial ecosystem and business environment of the招商街道 as an optimal location for the implementation of Hong Kong's technology transfer projects [1][2] - The team is focusing on a core project that provides fully humanized mice for M3H7 antibody research, which can significantly shorten drug development cycles and has high industrial application value [1] - The招商街道 leverages policy advantages and industrial foundations from the Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone to support the landing of Hong Kong technology projects [2] Group 2 - The招商街道 has hosted over 150 various service activities since its establishment in September 2024, covering 2,800 enterprises and over 30,000 participants, promoting inter-enterprise communication and cooperation [7] - The "Employment Service Station" and public recruitment fairs attracted 400 companies, providing nearly 3,000 job positions, effectively promoting employment [7] - The招商街道 has facilitated financing and credit limits totaling 428 million yuan for local enterprises through its financial service station [7] Group 3 - Shenzhen Youjie Zhixin Technology Co., a specialized enterprise in the招商街道, focuses on the development of offline AI voice control chips and holds over 100 authorized invention patents [8] - The company received a low-interest loan from the Industrial and Commercial Bank of China, enhancing its funding for research and development [8] - Participation in the "Walk into the Skyworth Group" industry chain docking event has led to fruitful product and investment discussions with Skyworth Group [8]

Core Viewpoint - Hu Guang Co., Ltd. has officially signed a strategic cooperation agreement with Zhongke Jingshang to focus on the research and development of industrial intelligence and robotics products [1] Group 1 - The collaboration will leverage Star Flash wireless communication technology [1] - The partnership aims to develop an industrial intelligent "brain information processing platform" [1] - Both companies will engage in government project cooperation applications and explore new market opportunities [1] - The agreement includes joint efforts in chip research and development [1]

2025年12 月13日， 摩尔线程智能科技的标志。视觉中国 图 12月12日，摩尔线程公告称，公司及实施募投项目的子公司计划使用最高不超过人民币75亿元的闲置募 集资金进行现金管理，使用期限自董事会审议通过之日起12个月内有效。在上述额度及期限范围内，资 金可以循环滚动使用。资金来源为IPO募集的资金75.7亿元，已经在2025年11月28日全部到位。 智通财经记者 周玲 日前，摩尔线程拟将IPO募集的资金不超过75亿元用于投资理财引发了广泛的关注。有投资者质疑摩尔 线程把募资拿去理财而不是投入原披露的项目计划。 12月13日，摩尔线程相关负责人做出解释称，公司前期明确披露了募集资金的项目计划，所募75亿资金 有分阶段、明确的研发、技术升级等一系列使用安排，也将严格按照既定募投项目计划的推进。 这位负责人表示，项目实施周期为三年，资金支出将根据项目进度分阶段拨付。因为项目是分阶段投 入，现阶段为提升募集资金使用效率，在确保募投项目顺利实施、不影响原有资金安排、且保障募集资 金安全的前提下，当前公司拟对部分尚未暂时闲置的募集资金进行现金管理，以合理提高资金收益，符 合公司及全体股东的利益。 同时，该负责人还表 ...

Core Viewpoint - Moore Threads announced the use of idle raised funds for cash management to improve efficiency without affecting project implementation or fund safety [2][4]. Group 1: Fund Management - The company plans to use up to RMB 750 million of idle raised funds for cash management within 12 months from the board's approval [2]. - The total amount raised from the initial public offering was approximately RMB 8 billion, with a net amount of RMB 7.58 billion after deducting issuance fees [4]. - The cash management amount is a maximum limit and will be less than this cap, with the amount decreasing as projects progress [4][5]. Group 2: Project Allocation - The funds raised are allocated to several projects: RMB 2.51 billion for AI chip development, RMB 2.502 billion for graphics chip development, RMB 1.982 billion for AI SoC chip development, and RMB 1.006 billion for working capital [4]. - The company emphasizes that cash management will not impact the normal operation of fundraising projects or the main business [5]. Group 3: Response to Concerns - The company has addressed external concerns by stating that the cash management strategy is in line with legal requirements and will not hinder project progress [5]. - The company is committed to increasing R&D investment to accelerate product iteration and overcome technical barriers [5].

Core Viewpoint - The company plans to use up to 7.5 billion RMB of its IPO funds for cash management, which has raised concerns among investors about the allocation of funds away from previously disclosed project plans [1][2]. Group 1: Fund Allocation and Management - The company clarified that the 7.5 billion RMB will be used for cash management to enhance fund efficiency while ensuring the smooth implementation of investment projects [1][2]. - The cash management amount is a maximum limit and the actual amount used will be significantly lower, with a dynamic reduction as projects progress [1][2]. - The cash management will involve safe and liquid investment products, including but not limited to time deposits and structured deposits [2]. Group 2: Project Implementation and R&D Focus - The company emphasized its commitment to increasing R&D investment to accelerate product iteration and overcome core technology barriers [2]. - The audit committee confirmed that the cash management plan complies with legal regulations and will not affect the normal implementation of fundraising projects or the company's main business [3]. - The total funds raised from the IPO amount to 8 billion RMB, designated for various AI chip development projects and working capital [3]. Group 3: Market Performance - As of December 12, the company's stock price was 814.88 RMB per share, reflecting a decline of 13.41%, with a total market capitalization of 383 billion RMB [4].

Group 1 - The company announced plans to use up to 7.5 billion yuan of idle raised funds for cash management, emphasizing that this will not affect the implementation of fundraising projects [2] - The cash management amount is a ceiling and the actual amount will be significantly lower, with the scale of idle funds expected to decrease as projects progress [2] - The company has a clear plan for the use of the raised funds, which includes phased investments in research and technology upgrades over a three-year period [2] Group 2 - The company will continue to increase R&D investment to accelerate product iteration and overcome core technological barriers, ensuring that cash management does not impact the normal development of fundraising projects and main business [3]

Core Viewpoint - The company, Moore Threads, announced plans to utilize up to 7.5 billion yuan of idle raised funds for cash management, emphasizing that this will not affect the implementation of its fundraising projects and main business operations [3][4]. Group 1: Fund Management - The company disclosed that the 7.5 billion yuan is the upper limit for cash management, and the actual amount will be significantly lower than this limit [3]. - The cash management is intended to enhance the efficiency of fund usage while ensuring the smooth implementation of fundraising projects and safeguarding the raised funds [3][4]. - The company plans to allocate funds in phases over a three-year project implementation cycle, with expenditures based on project progress [3]. Group 2: Research and Development - The company will continue to increase its investment in research and development to accelerate product iteration and overcome core technological barriers [4]. - There is a commitment to building a self-controlled technology and product system, ensuring that cash management does not impact the normal development of fundraising projects or the company's main business [4].

Core Viewpoint - The company plans to utilize up to 7.5 billion yuan of idle raised funds for cash management while ensuring that the implementation of fundraising projects and the normal development of its main business are not affected [2][4]. Group 1: Fund Management - The company has announced a maximum cash management limit of 7.5 billion yuan, which does not represent the actual amount to be managed, as the real cash management amount will be significantly lower than this cap [3]. - The cash management is intended to enhance the efficiency of fund usage without impacting the established fundraising project plans, ensuring the safety of the raised funds [2][3]. Group 2: Research and Development Focus - The company will continue to increase its investment in research and development to accelerate product iteration, tackle core technological barriers, and build a self-controlled technology and product system [4].

公司基于自主研发的MUSA架构，将保持较高研发投入和进行产品迭代。但与部分国际巨头相比，公司 在综合研发实力、核心技术积累、产品客户生态等方面仍存在一定的差距。公司目前新产品和新架构均 处于在研阶段，量产及产生收入仍需一定时间。 格隆汇12月11日丨摩尔线程(688795.SH)公布，公司将于近期召开首届MUSA开发者大会，预计短期内 对公司经营业绩不会产生重大影响。公司新产品尚未产生收入，产品实现销售尚需要经过产品认证、客 户导入、量产供货等环节，均存在不确定性。新产品在市场竞争中未能取得优势，或遭遇技术迭代滞 后、市场需求不及预期、关键客户导入失败或流失、量产供货困难等不利情形，将对公司的整体经营业 绩和财务状况产生不利影响。 ...